ClinicalTrials.Veeva

Menu

Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b

H

Hebei Medical University

Status

Not yet enrolling

Conditions

Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy

Treatments

Procedure: Sixty patients with early gastric cancer in stage T1bN0-1M0 were divided into Group A-N0 and Group B-N + according to the presence or absence of lymph node metastasis. When the enrolled patients und

Study type

Interventional

Funder types

Other

Identifiers

NCT06934824
FUTURE11

Details and patient eligibility

About

For patients diagnosed with early gastric cancer involving submucosal invasion, super-ESD indications, or lymph node metastasis, a combination of preoperative endoscopic ultrasound and abdominal contrast-enhanced CT was utilized to ascertain the depth of tumor invasion and to identify any suspicious metastatic lymph nodes in the vicinity of the stomach. Subsequently, a local full-thickness resection, coupled with or followed by individualized precise lymph node dissection, was conducted to fulfill the following objectives: ① To investigate the safety, feasibility, and efficacy of local resection for patients meeting super-ESD criteria; ② To offer a clinical foundation for the individualized and precise lymph node dissection treatment of early gastric cancer.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18-70 years old;
  2. Endoscopic pathological diagnosis: adenocarcinoma;
  3. Enhanced abdominal CT combined with endoscopic ultrasound clinical staging: T1bN0-1M0.
  4. Has not received other treatment;
  5. No other serious comorbidities;
  6. Agree to participate in the study and sign the informed consent form.

Exclusion criteria

  1. Pregnant or breastfeeding women
  2. History of previous abdominal surgery
  3. History of other previous malignancies
  4. Can patients with severe heart, lung, brain diseases tolerate surgical treatment

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Group A
Experimental group
Description:
Patients in group A-No lymph node metastasis, who underwent simple Double-Endoscopic Combined with local full-thickness resection.
Treatment:
Procedure: Sixty patients with early gastric cancer in stage T1bN0-1M0 were divided into Group A-N0 and Group B-N + according to the presence or absence of lymph node metastasis. When the enrolled patients und
Group B
Experimental group
Description:
Patients in group B-imaging examination showed lymph node metastasis. patients were randomly divided into Group N + a and Group N + b. Group N + a: Local full-thickness gastric wall and lymph nodes dissection on D1 or D1 + were performed with Double-Endoscopic Group N + b: Traditional standard surgical gastrectomy and D1 or D1 + lymph nodes dissection was performed .
Treatment:
Procedure: Sixty patients with early gastric cancer in stage T1bN0-1M0 were divided into Group A-N0 and Group B-N + according to the presence or absence of lymph node metastasis. When the enrolled patients und

Trial contacts and locations

0

Loading...

Central trial contact

Qun Zhao, Ph.D; Gang pei Yang, Master's degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems